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Abstract
This review provides a summary of recent research advances in elucidating the biosynthesis of 
fungal indole alkaloids. Different strategies used to incorporate and derivatize the indole/indoline 
moieties in various families of fungal indole alkaloids will be discussed, including tryptophan-
containing nonribosomal peptides and polyketide-nonribosomal peptide hybrids; and alkaloids 
derived from other indole building blocks. This review also includes discussion regarding the 
downstream modifications that generate chemical and structural diversity among indole alkaloids.
1 Introduction
Indole alkaloids, one of the largest classes of nitrogen-containing secondary metabolites, 
contain one or more indole/indoline moieties.1 They are widely found in plants, bacteria, 
fungi and animals. Fungi, especially Ascomycota, have been reported as prolific producers 
of indole alkaloids, many of which display potent biological activities.2 In recent years, the 
availability of fungal genome sequences has significantly accelerated the identification of 
biosynthetic genes involved in the biosynthesis of secondary metabolites from fungi.3, 4 
Heterologous expression of biosynthetic genes has also provided detailed biochemical 
understanding of the enzymatic steps, including those involved in the biosynthesis of indole 
alkaloids.5
Different strategies to incorporate indole into the final alkaloid structures are found in fungal 
secondary metabolism. Not surprisingly, most of the indole precursors are related to L 
tryptophan (1), the most abundant indole-containing species in the cell. The biosynthesis of 
1 itself starts from chorismate in the shikimic acid pathway and involves the intermediates 
anthranilate (2) and indole-3-glycerol-phosphate (3). Intermediate 3 is transformed into 
indole, which can be coupled with serine to form 1.6 Tryptophan 1 can be decarboxylated 
and converted into tryptamine (4),7 or be prenylated at C4 to yield 4-dimethylallyl 
tryptophan (4-DMAT) (5).8 Feeding experiments with isotope-labeled precursors showed 
that 1, as well as 3, 4 and 5 can each serve as the biosynthetic precursor for the indole/
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i. 1 can be directly activated by the adenylation domains of nonribosomal peptide 
synthetases (NRPSs) and be incorporated into NRPs and polyketides-NRP hybrid 
compounds. Indole alkaloids derived from cyclic dipeptides such as meleagrin (6) 
from Penicillium chrysogenum,12 quinazoline-containing tripeptides 
tryptoquialanine (7) from Penicillium aethiopicum13 and polyketide-containing 
tetramic acids are examples that incorporate 1 using this mechanism.
ii. The tryptophan precursor 3 can be an efficient indole donor as the glycerol-
phosphate moiety at C3 can be substituted by an electrophile and leave as 
glyceraldehyde 3-phosphate. 3 serves as the indole donor during the biosynthesis of 
1. The same chemistry is employed in the synthesis of indole diterpene family of 
fungal natural products, such as paxilline (8) from Penicillium paxilli,14, 15 in 
which 3-geranylgeranyl indole is formed upon C3 prenylation of 3.
iii. 1 can be prenylated at C4 by 4-dimethylallyl tryptophan synthase (4-DMATS) to 
yield 5,16 which can undergo several oxidative cyclization steps that lead to the 
formation of the characteristic ergoline ring (a fused tetracyclic system) found in 
ergot alkaloids.17
iv. Decarboxylation of 1 leads to the formation of tryptamine 4, which is a widely used 
building block in the biosynthesis of plant indole alkaloids. For example, the 
biosynthesis of monoterpene indole alkaloids from plant shares the common 
precursor strictosidine, which is the product of the enzymatic Pictet–Spengler 
condensation18 between tryptamine and an iridoid monoterpene secologanin 
catalyzed by strictosidine synthase.19 A few fungal indole alkaloids, such as 
communesin F (9) from the communesin family of natural products, also have one 
of the indole moieties derived from 4.10 However, biochemical evidences that 
confirms the direct incorporation of 4 as a precursor has not been reported. 
Interestingly in 9, the second indole moiety is derived from 5, illustrating a 
differential use of indole precursors in the same molecule.10
2 Biosynthetic Reactions on the Indole Ring
Incorporation of the indole ring into alkaloid scaffolds endows powerful reactivity that can 
lead to dramatic morphing of the compound into complex, polycyclic structures. This is due 
to the unique chemistry of the benzopyrrole bicyclic ring system to undergo reaction at three 
sites, N1, C2 and C3. Indole can undergo a variety of electrophilic substitution 
modifications at C2 and C3, and can be subject to epoxidation at C2-C3, which inverts the 
polarity on C2 and leads to nucleophilic addition at this position. Indeed, the rich reactivity 
of indole has rendered it a “privileged structure” in drug discovery.20, 21 Here a brief 
overview of biosynthetic transformations involving indole will be discussed.
2.1 Electrophilic Substitution/Addition
Indole is an electron-rich heterocycle because of the conjugated nitrogen lone pair. 
Electrophilic substitution occurs readily on indole in the five-membered pyrrole ring since it 
is more electron rich compared to the benzene ring.22 During the biosynthesis of indole 
alkaloids, the most commonly observed electrophile added to the indole ring is the 
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dimethylallyl carbocation generated from dimethylallyl-pyrophosphate (DMAPP). Of the 
three positions on the pyrrole ring, C3 is the preferred site to electrophilic addition. 
Although in most cases C3 is substituted, there is still a strong preference for attack at this 
position to give an iminium ion (Scheme 2A). The iminium species can be further subjected 
to C2 nucleophilic addition, frequently by an intramolecular nucleophile, to yield a fused 
indoline structure (Scheme 2A). The iminium ion can also undergo Plancher rearrangement 
in which alkyl migration yields a C3 arenium cation intermediate, that can be aromatized 
through C2 deprotonation to afford a 3-substituted 2-alkyl-indole (Scheme 2A).23 Although 
there is a lack of evidence for the existence of the C3 arenium cation intermediate during 
indole prenylation, it is likely that C2 prenylation of a C3-substituted indole proceeds in this 
route.24, 25 This is also partially supported by the observation of both C2 and C3 prenylated 
products during the biochemical characterization of an indole prenyltransferase (PTase).26 
An analogous prenyl migration was also proposed to take place between C3 and C4 
positions via Cope rearrangement in the reaction catalyzed by fungal 4-DMATS.27 In 
addition to prenylation, S-adenosylmethionine (SAM)-dependent C3 methylation is another 
example of electrophilic addition, such as during the biosynthesis of physostigmine, a 
pyrroloindole drug found in Streptomyces species.28
2.2 Indole Epoxidation
The C2-C3 double bond in indole can also be epoxidized by a flavin-dependent 
monooxygenase (FMO). The resulting indole 2, 3-epoxide is in equilibrium with a 
hydroxyiminium ion due to the epoxide ring-opening reaction initiated from the nitrogen 
lone pair. The hydroxyiminium species is electrophilic and can be readily attacked at C2 by 
a nucleophile and form a C3-hydroxylated indoline. The nucleophilic attack can be 
frequently intramolecular, such as from the amide nitrogen as in the case during notoamide 
D biosynthesis,29 or be intermolecular, as from a free amino group during biosynthesis of 
7.13 Interestingly, the presence of a C6 O-substitution in the benzyl ring can direct the 2, 3-
epoxide intermediate to open at C3 position and undergo a semipinacol-like rearrangement, 
which results in the migration of the C2-substitution to C3 position to form a substituted 2-
indolone, as in biosynthesis of notoamide C.29 (Scheme 2B)
3 Biosynthetic Categories of Indole Alkaloids
3.1 Peptide Indole Alkaloids Synthesized from NRPS
NRPSs are large multimodular enzymes that assemble nonribosomal peptide (NRP) natural 
products through activating and joining of amino acid building blocks. Indole-containing 
NRPs are produced when a NRPS module incorporates an L-tryptophan into the final 
compound. Adenylation (A) domains in NRPSs are responsible for activation of individual 
amino acids, and formation of aminoacyl thioesters attached to the thiolation (T) domains. 
Prediction of A domain substrate specificity has been successful for bacterial A-domains 
and has been developed into automated web-based resources.30-32 This method is based on 
the identities of residues within a radius of ~8 Å around the catalytic center (34-position 
signature sequence, as well as a concise 10 amino acid code) when mapped to the structure 
of the phenylalanine-activating A domain PheA.33, 34 Application of this method towards 
predicting fungal A-domain specificity has been limited, with only few successful examples 
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such as for anthranilic acid (2).35 Known bacterial NRPSs that utilize 1 as building block are 
relatively rare. A sequence logo36 representation of the 10 AA code for A-domains specific 
for 1, from five bacterial32 and eight fungal NRPS examples, are shown in Figure 1. For 
comparison purpose, a comprehensive sequence logo of the 10 AA for >800 fungal A 
domains32 is shown. Among A domains that activate 1, a valine residue at position 330 
(numbering based on PheA) is highly conserved in addition to the general ‘invariant’ 
residues D235 and K517. Another moderately conserved residue is at position 236, which is 
occupied by less bulky hydrophobic residues (Val, Gly, Ala, etc.).33 Although the 10 AA 
code (or signature sequences) in fungal NRPSs is less informative due to the lack of 
sufficient sequence-specificity relationship studies, the sequence logo representation can be 
used to predict, confirm or exclude A domain specificity for 1.
Most fungal indole alkaloids biosynthesized from NRPSs can be classified into either a 
dipeptide that involves formation of diketopiperazine; or an anthranilate-containing 
tripeptide that undergoes cyclization to contain a quinazoline core. There are larger NRP 
products that contain 1, such as the tetrapeptide apicidin isolated from Fusarium semitectum 
that displays histone deacetylase inhibition activity.37, 38 Due to space constrains, alkaloids 
originated from more than tripeptide NRPs will not be discussed here.
3.1.1 Dipeptide Indole Alkaloids—Dipeptidyl indole alkaloids are assembled by 
bimodular NRPSs, in which two amino acids are activated and condensed together. The 
second amino acid has been found to be L proline, L-histidine, L-phenylalanine, L-alanine or 
another molecule of 1.39 Aminoacyl-Trp is condensed with the second amino acid moiety to 
yield a linear dipeptidyl thioester. This product can undergo intramolecular cyclization in 
which the free amino group of 1 attacks the aminoacyl thioester to release the characteristic 
diketopiperazine (Scheme 3A).40 The cyclization reaction is likely catalyzed by the C-
domain that is appended at the end of the bimodular assembly line, although this reaction 
can also proceed spontaneously.
A prolinyl-tryptophanyl dipeptide forms the diketopiperazine intermediate brevianamide F 
(10), which can be transformed into a large family of compounds, including tryprostatins,41 
spirotryprostatins,42 fumitremorgins43 and notoamides.44 10 can be converted to tryprostatin 
B (11) through a normal C2 prenylation by a PTase such as FtmB in the fumitremorgin 
pathway from Aspergillus fumigatus A116343 or to deoxybrevianamide E (12) through a 
reverse prenylation catalyzed by NotF in notoamide pathway from Aspergillus sp. 
MF297-245. 11 is an on-pathway intermediate in the biosynthesis of numerous products as 
shown in Scheme 3A. 12 can be converted into brevianamides such as notoamide, 
stephacidins, versicolamide, etc., in which the reverse prenyl group plays an important role 
in the formation of the bicyclo[2.2.2]diazoctane ring.46, 47
11 and its 6-methoxy version (tryprostatin A) can undergo oxidative coupling between the 
prenyl group and the diketopiperazine ring to form a fused 6-5-6-6-5 ring system as found in 
demethoxyfumitremorgin C (13) or fumitremorgin C (14). This reaction is proposed to be 
catalyzed by a cytochrome P450 monooxygenase (CYP) such as FtmE in the fumitremorgin 
pathway.48 Spirotryprostatins can be synthesized through further oxidative modifications via 
two distinct routes.49 One route is through a radical-mediated, two-step hydroxylation on 13 
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and 14 followed by dehydration and semipinacol-type rearrangement to form spirotryprostin 
B (15) and G (16), which is catalysed by the CYP FtmG (Scheme 3A).49 Another route is 
through epoxidation of the indole 2,3-double bond by an FMO followed by a semipinacol-
type rearrangement. FtmG can also hydroxylate 14 twice and the resulting molecule can be 
converted to fumitremorgin B after N-prenylation by FtmH.48, 50 Further oxidation by a 
Fe(II)-dependent α-ketoglutarate dioxygenase gives verruculogen (17).51
During notoamide biosynthesis, 12 is modified by C6 hydroxylation and C7 normal 
prenylation to afford the common intermediate notoamide S (18). 18 serves as the branching 
point of subsequent biosynthetic steps towards either notoamide C (19) or notoamide B (20). 
To form 19, The C6 hydroxyl and C7 prenyl group are first oxidatively coupled to give 
notoamide E; which can be epoxidized at the C2 and C3 of the indole by NotB.29 Whereas a 
semipinacol rearrangement on the hydroxyiminium intermediate gives 19, a nucleophilic 
attack from the α-amide of Trp (now part of diketopiperazine) forms notoamide D. 
Alternatively 18 can undergo dehydrogenation in the diketopiperazine ring to an achiral 
azadiene, which can form the bicyclo[2.2.2]diazoctane ring through intramolecular Diels-
Alder reaction (IMDA).46, 47 Whether the IMDA reaction is enzymatic or spontaneous is 
still unresolved because both stereoisomers of the cycloadduct are observed in nature.46 
Additional oxidative steps, including a similar prenyl migration as proposed for 19, are 
required to produce (+) or (−)-20 in A. sp. MF297-2 (Scheme 3A).
Meleagrin (6) is an example of indole alkaloids derived from a histidyl-tryptophanyl 
diketopiperazine (HTD) (21). Biosynthetic studies of the meleagrin pathway have been 
performed in Penicillium chrysogenum.12, 52 The gene cluster (roq) has been named after a 
well-known intermediate roquefortine C (22). In this seven-gene cluster, RoqA is the 
bimodular NRPS that synthesizes HTD. C3 reverse prenylation and intramolecular ring 
fusion catalyzed by the PTase RoqD yields a 6-5-5-6 ring system.52 α-β dehydrogenation of 
the histidyl component by the P450 oxidoreductase RoqR affords 22. Based on both gene 
silencing and gene deletion studies, the prenylation and dehydrogenation steps can take 
place independent of each other.12, 52 22 can be further converted into 6 and the O-
methylated derivative oxaline that shows antimicrobial and anticancer activities.53, 54 The 
conversion to 6 involves a proposed oxidative rearrangement by a Maackiain 
monooxygenase RoqM, followed by indole N1 methoxylation by RoqO (cytochrome P450) 
and RoqN (methyltransferase).52 The oxidative rearrangement that generates the unique 
6-5-6-5 ring skeleton was proposed to initiate through hydroxylation on the diketopipyrazine 
ring to form an acyloin, followed by ring opening and oxidative ring closure through a 9-
membered ring β-ketoamide intermediate (Scheme 3B).55
Acetylaszonalenin (23), a benzodiazepinedione isolated from Neosartorya fischeri 
NRRL181, is derived from the dipeptide R-benzodiazepinedione (24). The pharmacophore 
24 is assembled by a bimodular NRPS (AnaPS) that combines 2 and 1 (Scheme 3C), and 
involves epimerization of the indole side chain.13, 56 The release/cyclization of the dipeptide 
product is shown to take place spontaneously using model substrates.57 Excision of the 
terminal epimerization domain in AnaPS led to the production of the S-stereoisomer in vitro, 
albeit with significantly reduced yield compared to that of 24.58 C3 reverse prenylation on 
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24 initiates intramolecular cyclization and form the fused indoline-benzodiazepine 
aszonalenin (25). Further acetylation at position N1 by an acetyltransferase (AnaAT) arrives 
at 23 (Scheme 3C).56
3.1.2 Tripeptide Indole Alkaloids—Fungal indole alkaloids containing three amino acid 
building blocks are synthesized by trimodular NRPSs (with the exception of asperlicin (26), 
see below). In addition to the incorporation of 1, a frequently used building block is the β-
amino acid anthranilate 2. As a result of incorporation of 2, structurally complex tripeptidyl 
alkaloids can be synthesized from surprisingly short biosynthetic pathways.59 The amino 
and carboxylic acid functional groups in 2 are ortho to each other, which makes 2 a unique 
building block in the construction of multicyclic ring systems. One effective way of 
harvesting the reactivity and geometry of 2, which is always the first amino acid 
incorporated by the trimodular NRPS, is through a condensation like domain (CT) 
positioned at the C-terminal end of the NRPS assembly line. The CT domain catalyses the 
macrocyclization and the release of the tripeptide through nucleophilic attack of the aniline 
nitrogen of 2 on the peptidyl thioester (Scheme 4A). Depending on the sequence of the 
peptide, either a ten-membered (most frequent) or eleven-membered macrolactam can be 
formed, which can undergo additional intramolecular cyclization reactions to yield products 
such as a 6-6-6 tricyclic pyrazinoquinazolinedione as shown in Scheme 4A or an angular 
6-6-7-6 tetracyclic pyrazinobenzodiazepinedione as asperlicin C (27).
The first biochemically characterized tripeptide alkaloid is fumiquinazoline F (FQF, 28), 
which is cyclized from Ant-D Trp-Ala.60 28 serves as an intermediate in the biosynthesis of 
more complex alkaloids, such as fumiquinazoline D (29) in A. fumigatus; and 
tryptoquialanine (TQA, 7), a tremorgenic toxin from P. aethiopicum. The trimodular NRPS 
from the tqa biosynthetic pathway, TqaA, has been expressed from Saccharomyces 
cerevisiae and functionally reconstituted in vitro.58 Synthesis of 28 can be observed upon 
incubation of the amino acid substrates and cofactors in the presence of TqaA Removal of 
CT led to the hydrolysis of the linear tripeptide, which does not spontaneously cyclize under 
aqueous conditions. When the tripeptide is tethered to the last T domain of TqaA, the 
standalone CT domain catalysed the formation of 28. Substrates analogues of the tripeptide 
were used to probe the reaction catalysed by the CT, which led to exclusion of a 
diketopiperazine cyclization route in favour of the macrocyclization step shown in Scheme 
4A.58
In the biosynthetic pathways of both 29 and 7, the indole ring in 28 is epoxidized by a FMO 
(Af12060 or TqaH).60 Interestingly, Af12060 was shown to also epoxidize the 
diketopiperazine 14 en route to spirotryprostatin A in A. fumigatus, hinting a shared indole 
epoxidase between unrelated pathways in fungi.49 The resulting oxy-fumiquinazoline F (30) 
is in equilibrium with the C3 hydroxyiminium species (Scheme 4B). Although 30 is the last 
shared intermediate for the FQF and TQA pathways, the subsequent modifications are 
chemically parallel. In both pathways, a single-module NRPS activates either alanine (by 
Af12050) or aminoisobutyrate (by TqaB) to the corresponding aminoacyl thioesters, and 
catalyses the attack of the free amino group on C2 of 30 to yield an adduct.13, 60 The 
nucleophilic attack on the indole is catalysed by the terminal C domains in the monomodular 
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NRPSs, which control the relative stereochemistry of the C2-C3 substituents (syn or anti).13 
Subsequently, nucleophilic attack of the indole nitrogen on the NRPS thioester completes 
the 6-5-5 imidazoindolone ring substructure and yields either fumiquinazoline A (31) or 15-
dimethyl-2’-epi-FQA (32). The last parallel step between the two pathways is the 
dehydrogenation of the pyrazinoquinazolinedione ring by a FMO Af12070 or TqaG, to yield 
a reactive imine. In the biosynthetic pathway of 29, the imine intermediate is attacked by 
nucleophiles from the imidazoindolone portion to form either a cyclic hemiaminal-
containing fumiquinazoline C (FQC); or an aminal-containing, thermodynamic product 29. 
In contrast, in the TQA pathway, the imine intermediate undergoes ring-opening 
deamination, spirolactonization and additional modifications to yield the final product 7. 
The structurally related product tryptoquivaline found in A. clavatus61 is synthesized by the 
same overall pathway starting from the tripeptide Ant-D-Trp-Val.
Compared to 28, the biosynthesis of ardeemin (33) from Aspergillus fischeri involves the 
same three amino acids but with a different order of incorporation.62 The trimodular NRPS 
ArdA synthesizes the tripeptide Ant-D-Ala-Trp, which is cyclized into the 
pyrazinoquinazolinedione intermediate ardeemin FQ (34) by the CT domain of ArdA.62 
Instead of epoxidation on the indole ring as observed in 28, the C3 reverse prenylation by 
PTase ArdB generates the iminium cation that is attacked intramolecularly by α-amide of 
Trp (now as part of the pyrazinoquinazoline) to yield the hexacyclic (6-6-6-5-5-6) ring 
system in 33 (Scheme 4C).62 The prenylation/cyclization reactions performed by ArdB is 
analogous to those catalysed by AnaPT in the synthesis of 23,56 and further illustrate the 
high degree of structural complexity that can be generated from alkylation of the indole 
moiety. ArdC, an AnaAT homolog, is proposed to acetylate the indole N1 position to afford 
N-acetylardeemin (35).56
The biosynthesis of asperlicin (26) involves an example of iterative function of a fungal 
NRPS module. Whereas three amino acids (two 2 and one 1) are proposed to constitute the 
peptidyl backbone, genome scanning of Aspergillus alliaceus revealed one bimodular NRPS 
AspA that may be involved in the biosynthesis.62 Prediction of the specificities of the two A 
domains suggested that 2 and 1 should be activated sequentially. In vitro reconstitution of 
AspA purified from S. cerevisiae confirmed its function, as asperlicin C (27) was the 
dominant product formed accompanied by minor product asperlicin D.63 Adenylation 
domain activation assays confirmed the predicted specificities and excluded dianthranilate 
being activated by the first module. Thus ArdA is proposed to first synthesize an Ant-Trp 
dipeptidyl thioester, followed by activation of a second molecule of 2 and formation of the 
Ant-Ant-Trp tripeptidyl thioester. The CT domain of AspA was confirmed to catalyse 
cyclization of the tripeptide into a proposed eleven-membered macrolactam intermediate.63 
The consequent transannular cyclization from attack of α-amide of Trp on the Ant carbonyl 
results in the formation of the minor product asperlicin D, while attack from the Ant amide 
on the Trp carbonyl leads to the on-pathway product 27.63 Epoxidation of the indole in 27 
requires the FMO AspB that is functionally parallel to Af12060 and TqaH. Nucleophilic 
addition from the α-amide of Trp (now part of the benzodiazepinedione) affords the 
heptacyclic compound asperlicin E (36).62 Hence, a remarkable two enzyme cascade (AspA 
and AspB) transforms two molecules of 2 and one molecule of 1 into a spectacularly 
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complex multicyclic ring system. Alternatively a monomodule NPRS AspC can annulate the 
indole ring with one molecule of leucine to yield the isoindolone containing 26, similar to 
the function of TqaB in the synthesis of 32.62
3.2 Hybrid Indole Alkaloids Synthesized from PKS-NRPS
A tryptophan-activating NRPS module can also be fused to fungal iterative polyketide 
synthases (IPKSs) to insert indole moieties. Fungal IPKSs are highly programmed 
assembly-line machineries that can synthesize a large diversity of structures.64, 65 A typical 
NRPS module domain arrangement is C-A-T-R, in which the C (Condensation) domain 
catalyses the transfer of the completed polyketide acyl group to the α-amine of the 
aminoacyl thioester attached to the T domain. The terminal R (reductase) domain is 
proposed to reduce the final thioester product into an aldehyde followed by an 
intramolecular Knoevenagel condensation to yield a 3-pyrrolin-2-one core. Biochemical 
studies showed that the reductase-like domain is not always reducing: in some cases this 
domain functions as a Dieckmann cyclase (R* or DKC) that catalyses the attack of the α-
carbon of the 1,3-diketo polyketide portion on the thioester for tetramic acid formation and 
product release (Scheme 5).66 Examples of indole alkaloids derived from characterized 
PKSNRPS pathways include α-cyclopiazonic acid (CPA, 37) and chaetoglobosin A (38).
The pentacyclic 37 produced from Aspergillus flavus is a potent neurotoxin through 
inhibition of the sarcoplasmic Ca2+-ATPase.67 The cpa gene cluster contains three genes, a 
PKSNRPS (CpaS), a 4-DMATS (CpaD) and a flavoprotein oxidocyclase (CpaO).68 CpaS is 
proposed to synthesize the acetoacetyl-L-tryptophanyl thioester, which is cyclized by the 
terminal R* domain to yield cyclo-acetoacetyl-L-tryptophan (39) (Scheme 5A).69 
Subsequently, 39 is regioselectively prenylated by CpaD at C4 to yield β-cyclopiazonic acid 
(β-CPA, 40).70 Unlike 4-DMATS, CpaD displays low activity against substrates lacking 
tetramic acid or similar functionalities.70 The final cascade of transformations that convert 
40 to 37 is accomplished by CpaO, which most likely dehydrogenates β-CPA at the Cβ 
carbon of Trp, catalyses the electrophilic cyclization between the C3 and C4 substituents, 
and sets up a nucleophilic attack from the α-amide of Trp (now part of the tetramic acid) to 
afford the cis-pentacyclic 37 (Scheme 5A). Although the cyclized ring framework resembles 
that observed in ergot alkaloids, the cyclization mechanisms in these two pathways are 
drastically different.
Because of the reactivities associated with the indole ring, combinatorial matching of the 
CpaS NRPS module with PKSs that synthesize different polyketide products is an attractive 
method of generating new indole compounds. Working with the aspyridone PKS-NPRS 
ApdA from Aspergillus nidulans that incorporates tyrosine71, Xu et al showed that the PKS 
and NRPS modules can function independently, and can be excised and paired in trans. 
Interestingly, heterologous pairing of the ApdA PKS module with the CpaS NRPS module 
led to functional crosstalk and synthesis of a new indole-containing tetramic acid 41 
(Scheme 5B).72
Cytochalasans are a group of bioactive natural products that contain a highly substituted 
perhydroisoindolone core fused to a polyketide-derived macrocycle.73 Chaetoglobosins, 
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including chaetoglobosin A (38) from Chaetomium globosum, is a subgroup of 
cytochalasans that use 1 as a building block. The biosynthetic pathway of 35 centers on the 
PKS-NRPS megasynthetase encoded by CHGG_01239, which synthesizes a pentaene-
tryptophanyl product (Scheme 5C).74 The R domain in this PKS-NRPS is likely to be 
reductive and releases the acyclic product as an aldehyde, which can undergo spontaneous 
Knoevenagel condensation to form a doubly substituted pyrrolinone. A proposed 
intramolecular Diels-Alder (IMDA) reaction involving the pyrrolinone double bond and a 
specific diene in the polyketide portion of the acyclic molecule yields the key intermediate 
prochaetoglobosin (42), which can be furnished into 35 after a set of oxidative modifications 
that were recently worked out by Watanabe and coworkers.74
3.3 Indole Diterpenoids
Fungal indole diterpenes are indole-containing cyclic diterpenes found in numerous fungal 
species, including paxilline (8) from Penicillium paxilli,15 aflatrem from Aspergillus 
flavus,75 emindoles from Emericella desertorum,76 and lolitrem from Neotyphodium lolii 77, 
etc. This group of structurally complex molecules has a variety of biological activities, 
including inhibition of ion channels78 and active against MRSA.79 Early feeding 
experiments suggested that the terpenoid structure is derived from geranylgeranyl 
pyrophosphate (GGPP)80 and the indole moiety is derived from indole-3-glycerol-phosphate 
3.81 GGPP is synthesized from farnesyl pyrophosphate (FPP) by an encoded GGPP synthase 
in the gene cluster, such as PaxG in pathway of 8. The acyclic 3-geranylgeranyl indole (43) 
was proposed to be a precursor common to all indole diterpenes. In vitro assays of PaxC, the 
geranylgeranyl transferase from the pax pathway, confirmed that 43 can be synthesized from 
3 through geranylgeranyl addition at the C3 position followed by elimination of 
glyceraldehyde 3-phosphate.14 The differences in the oxidative cyclization steps from 43 
generate structure diversity among the resulting cyclic products. Genetic studies showed that 
a flavin-dependent monooxygenase (PaxM) and an integral membrane protein (PaxB) are 
required for the transformation of 43 to paspaline (44), the fully cyclized precursor of 8.82 
These two enzymes, along with PaxC and PaxG, are well-conserved in the genomes of 
indole diterpene producing fungi.75, 77 Using a combination of heterologous expression and 
biotransformation in Aspergillus oryzae, Oikawa and coworkers showed that PaxM catalyses 
two epoxidation reactions on the diterpene portion of 8, while PaxB serves as the terpene 
cyclase (Scheme 6).14 The electron-rich indole moiety is involved in the later steps of the 
carbocation-based cyclizations, resulting in the formation of the 6-5-5-6-6-6 fused ring 
system in 44. In vitro assays showed that PaxB can accept either the bis-epoxide containing 
diterpene 46 or mono-epoxide intermediate 45 to yield 44 and emindole SB (47) 
respectively. PaxB and its homologs therefore play an important role in dictating the 
regioselectivity and stereoselectivity of the final products. In forming 44 and 47, an anti-
Markovnikov addition is required during the cyclization steps (Scheme 6), while a 
Markovnikov addition would lead to a structurally different subfamily including emindole 
DA (48).83 The regioselectivity and timing of the epoxidation reactions catalyzed by PaxM 
homologs also have a profound impact on the structure of the final products.
Additional enzymes present in the pathways can introduce further structural complexity and 
diversity to indole diterpenes, such as oxidative steps catalyzed by PaxP and PaxQ in 
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transformation of 44 to 8. Recent findings by Liu et al.84 showed derivatives of 8 that are C5 
mono-prenylated (paspalitrem A (49)) and C5/C6 diprenylated may be the final products in 
the pax pathway. Using recombinant PTase PaxD, the conversion of 8 to the prenylated 
derivatives was observed in vitro. Further search of the P. paxilli extract revealed the 
presence of these compounds, thereby suggesting the possibilities of 8 being a biosynthetic 
intermediate instead of a final product. A homologous PTase AtmD was found in the gene 
cluster of aflatrem, which catalyses the C4 reverse prenylation. AtmD was shown to have 
considerable substrate flexibility towards the indole diterpene substrates, and can perform 
either normal or reverse prenylation when presented with different substrates.85
3.4 Indole Alkaloids Derived from Other Building Blocks
While 1 and 3 are the main sources of the indole moiety in fungi, other tryptophan derived 
metabolites are also used in the construction of indole alkaloids. These include indole 
pyruvate (50), 4-DMAT (5) and tryptamine (4).
Asterriquinones are a group of prenylated indole-containing compounds derived from two 
molecules of 50. Members of this family share the common dihydroxybenzoquinone core 
and vary mainly in prenylation pattern on the indole portion. The genes involved in the 
biosynthesis of terrequinone A (51) in A. nidulans was identified using a genome-wide 
survey of transcriptionally activated natural product gene clusters.86 Subsequent 
biochemical study reconstituted the entire five enzyme pathway required for formation of 
51.87 As expected, 1 is first converted into 50 in a pyridoxal-5’-phosphate (PLP)-dependent 
fashion by the aminotransferase TdiD. A single-module NRPS TdiA with the domain 
organization of A-T-TE (TE: thioesterase) activates and couples two molecules of 50 to 
form didemethylasterriquinone D (52). Different from tryptophan-specific A domains, the A 
domain in TdiA is specific for the α-keto acid 50. The TE domain first serves as a waiting 
station in which the first molecule of 50 is covalently attached as an oxyester while the 
second molecule of 50 is activated as a thioester on the T domain; this is then followed by a 
TE-catalyzed head-to-tail dual Claisen condensation to form 52. The benzoquinone 52 can 
then be converted to 51 when incubated with TdiC (a zinc- and NAD(P)H-dependent 
quinone reductase), TdiB (an indole PTase) and TdiE (a methyltransferase like protein). 52 
is proposed to be reduced by TdiC to the corresponding bisindolylhydroquinone, which is 
electron-rich and can be prenylated on the hydroquinone core by TdiB. The regioselectivity 
of this prenylation step is directed by TdiE, which was proposed to be a chaperone protein. 
In contrast, indole prenylation by TdiB is not influenced by TdiE (Scheme 7).87
The biosynthesis of ergot alkaloids such as fumigaclavine C (53) goes through the 
intermediate 5, which can be synthesized from 1 by the action of dedicated 4-DMATS 
encoded in the individual gene clusters. The key intermediate in the biosynthesis of 53 is 
chanoclavine-I aldehyde (54), which is converted from 5 following a series of 
transformations including N-methylation, oxidative cyclizations and decarboxylation 
(Scheme 7). A detailed discussion of ergot biosynthesis can be found in a separate review 
article in this issue.
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Decarboxylation of 1 by the PLP-dependent tryptophan decarboxylase results in the 
formation of 4, which is major constituent of plant alkaloids.88 A limited number of fungal 
alkaloids incorporating 4 have been reported, with communesins synthesized from 
Penicillium species and perophoramidine from Perophora namei being the most 
notable.89, 90 Communesins, such as communesin F (9), have been reported to disrupt 
microfilament and lead to cytotoxicity to mammalian cells.89 The structural complexities of 
communesins, especially the cage-like polycyclic scaffold with four contiguous 
stereocenters and vicinal quaternary carbons, have attracted significant efforts from the total 
synthesis community.91-93 Both perophoramidine and communesins contain two connected, 
indole-derived halves. Isotope feeding experiments showed that both indoles originated from 
1.94 One of the incorporated indole moiety is prenylated at C4 and has remained intact. 
Stoltz et al. proposed that (-)-aurantioclavine (55), an ergot-like molecule derived from 5, is 
a building block that serves as the prenylated half of the communesin structure (Scheme 
7).95 The other incorporated indole in 9 is ring-opened and morphed into part of a 
benzylpyrrolidine. Feeding of 6-fluoro-tryptamine showed that the fluorine substitution was 
only found in the non-prenylated half of communesins, there by suggesting this half, which 
includes the pyrrolidine and aniline, are derived from 4.10, 94 The enzymatic coupling of the 
two indole containing precursor (possibly 55 and 4) in such a regioselective and 
stereoselective fashion is unprecedented. At this point, no genetic and biochemical 
information of communesin biosynthesis has been reported.
4 Conclusions
The discussion above described the different biosynthetic strategies to incorporate and 
derivatize indole moiety involved in biosynthetic pathways of fungal indole alkaloids. The 
characteristic enzymes that catalyze key modifications for each family of indole alkaloids, 
including tryptophan-activating A domain in NRPSs or PKS-NRPSs, TqaH-like FAD-
dependent indole epoxidases, 4-DMATS-like indole PTases, PaxB/PaxM homologs, and 
PLP-dependent tryptophan decarboxylases, can be fruitful leads for exploring new indole 
alkaloid pathways from sequenced fungal genomes. Such mining strategy combined with 
progressing techniques in molecular biology and microbiology, will accelerate the discovery 
of new fungal alkaloid natural products.
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Origins of Indole Moieties in Fungal Indole Alkaloids
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Common Reactions on Indole Ring.
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A sequence logo representation of the 10 AA code for NRPS A-domains specificity. A) A 
domains that are specific for 1. B) All the fungal A domains in NRPSpredictor2 database.32 
The residue numbering is based on PheA.33
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Biosynthesis of Dipeptide Indole Alkaloids.
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Biosynthesis of Tripeptide Indole Alkaloids
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Biosynthesis of PKS-NRPS Derived Indole Alkaloids
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Biosynthesis of Fungal Indole diterpenes.
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Biosynthesis of Indole Alkaloids from Other Indole Precursors
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